Efficacy and Safety of First-Line Checkpoint Inhibitors–Based Treatments for Non–Oncogene-Addicted NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis
ESMO Open 2022 Apr 12;7(3)100465, MA Siciliano, G Caridà, D Ciliberto, M d'Apolito, C Pelaia, D Caracciolo, C Riillo, P Correale, A Galvano, A Russo, V Barbieri, P Tassone, P TagliaferriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.